Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010
We read with interest the article by Kurian et al1 describing a young woman with opsoclonus-myoclonus syndrome (OMS) in the context of an anti–N-methyl-D-aspartate receptor (NMDAR) encephalitis. The clinical signs at presentation were speech difficulties, hypophonia, anxiety, and tremulous eye and head movement followed by increasing gait instability. She was diagnosed with depression and initially hospitalized in the psychiatric division.
Korn-Lubetzki I, Steiner-Birmanns B, Jaworowski S. Anxiety as Initial Diagnosis in Opsoclonus Myoclonus Syndrome. Arch Neurol. 2010;67(9):1154–1155. doi:10.1001/archneurol.2010.192
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: